Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Green Fresh Biotechnology CoHKSE:01084 -6.43%52 PE Ratio without NRI is 59.55 as of Aug. 18, 2026, which is 544% above its 10-year median of 9.25. GuruFocus rates HKSE:01084 with a GF Score™ of 52/100 and a GF Value™ of HK$0.55 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 1,456 Consumer Packaged Goods companies, Green Fresh Biotechnology Co ranks worse than 91.07% on this metric.
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-08-18), Green Fresh Biotechnology Co's share price is HK$0.655.
Green Fresh Biotechnology Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.01. Therefore, Green Fresh Biotechnology Co's PE Ratio without NRI for today is 59.55.
During the past 10 years, Green Fresh Biotechnology Co's highest PE Ratio without NRI was 73.00. The lowest was 2.54. And the median was 9.25.
Green Fresh Biotechnology Co (HKSE:01084) PE Ratio without NRI Explanation
The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.
If a company loses money, the PE Ratio becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.
Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.
Green Fresh Biotechnology Co PE Ratio without NRI Related Terms
Green Fresh Biotechnology Co PE Ratio without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Fresh Biotechnology Co PE Ratio without NRI Chart
HKSE:01084 vs ADM, BG, TSN: PE Ratio without NRI Comparison
For the Farm Products subindustry, Green Fresh Biotechnology Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Fresh Biotechnology Co PE Ratio without NRI vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Green Fresh Biotechnology Co's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Green Fresh Biotechnology Co's PE Ratio without NRI falls into.
Green Fresh Biotechnology Co PE Ratio without NRI Calculation
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.
Green Fresh Biotechnology Co's Share Price of today is HK$0.655.
For company reported semi-annually, Green Fresh Biotechnology Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.
For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Green Fresh Biotechnology Co (HKSE:01084) has a PE Ratio without NRI of 59.55 as of Aug. 18, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Green Fresh Biotechnology Co and its competitors. This is 544% above median its historical median of 9.25. Over the past decade, Green Fresh Biotechnology Co's PE Ratio without NRI has ranged from 2.54 to 73.00. According to the industry distribution chart, Green Fresh Biotechnology Co ranks #1326 out of 1456 companies in the Consumer Packaged Goods industry, placing it in the top 91.1%.
Is Green Fresh Biotechnology Co's PE Ratio without NRI too high?
Green Fresh Biotechnology Co's current PE Ratio without NRI of 59.55 is 544% above median its 10-year median of 9.25. Over the past 10 years, this metric has ranged from a low of 2.54 to a high of 73.00. The Consumer Packaged Goods industry median PE Ratio without NRI is 16.46. Green Fresh Biotechnology Co's value of 59.55 is 261.8% above this industry median. Based on the distribution chart, Green Fresh Biotechnology Co ranks #1326 out of 1456 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Green Fresh Biotechnology Co has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Fresh Biotechnology Co's PE Ratio without NRI compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Green Fresh Biotechnology Co ranks #1326 out of 1456 companies for PE Ratio without NRI. This places Green Fresh Biotechnology Co in the lower half of its industry. The industry median PE Ratio without NRI is 16.46. Green Fresh Biotechnology Co's value of 59.55 is 261.8% above this benchmark. Historically, Green Fresh Biotechnology Co's own PE Ratio without NRI has ranged from 2.54 to 73.00 over the past decade. While the company's 10-year median is 9.25 vs. the industry median of 16.46, Green Fresh Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Consumer Packaged Goods company?
The median PE Ratio without NRI among Consumer Packaged Goods companies is 16.46, based on 1,456 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Fresh Biotechnology Co's current PE Ratio without NRI of 59.55 is 261.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Green Fresh Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median PE Ratio without NRI is 16.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Fresh Biotechnology Co's current PE Ratio without NRI is 59.55, which is 544% above median its own 10-year median of 9.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Fresh Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co (HKSE:01084) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.55, compared to a current price of HK$0.66 — trading 19.1% above its estimated fair value. The current PE Ratio without NRI is 59.55, which is 544% above median its 10-year median of 9.25 and 261.8% above the Consumer Packaged Goods industry median of 16.46. Green Fresh Biotechnology Co's overall GF Score™ is 52/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Green Fresh Biotechnology Co (HKSE:01084), the current PE Ratio without NRI is 59.55 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Fresh Biotechnology Co (HKSE:01084) Overvalued in 2026?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co stock appears to be overvalued.
The current stock price of HK$0.66 is trading 19.1% above its estimated GF Value™ of HK$0.55.
GuruFocus considers Green Fresh Biotechnology Co to be Modestly Overvalued.
Key valuation signals for HKSE:01084:
PE Ratio without NRI: 59.55 (544% above median its 10-year median of 9.25)
GF Value™: HK$0.55 vs. price of HK$0.66 (19.1% above fair value)
Industry Position: 261.8% above the Consumer Packaged Goods median (#1326 of 1456)
No single metric tells the full story. See the HKSE:01084 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Fresh Biotechnology Co Ltd, formerly Green Future Food Hydrocolloid Marine Science Co Ltd is engaged in manufacturing and sales of food manufacturing hydrocolloid products including carrageenan products, agar-agar products, blended products, and konjac products in the People's Republic of China and overseas. Its segments include Manufacturing and sales of agar-agar products, which derives maximum revenue; Manufacturing and sales of carrageenan; Manufacturing and sales of konjac products; Manufacturing and sales of blended products; and Others, such as trading of seaweed powder and other operations. Its operations are spread across Chinese Mainland, which derives maximum revenue; Europe; Asia (excluding Chinese Mainland); South America; North America; Africa; and Oceania.
52GF Score
Get the complete analysis for HKSE:01084
PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01084 has been successfully added to your 
